Eagle Pharmaceuticals Inc.

04/30/2024 | Press release | Distributed by Public on 04/30/2024 06:04

Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric[...]